ETF Managers Group’s CureVac CVAC Stock Holding History

ETF Managers Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$531K	Buy	+76,144	New	+$664K	0.02%	439
2022 Q4	–	Sell	-55,320	Closed	-$436K	–	560
2022 Q3	$436K	Buy	55,320 +1,531	+3%	+$17.9K	0.01%	475
2022 Q2	$746K	Sell	53,789 -2,812	-5%	-$46.5K	0.02%	279
2022 Q1	$1.09M	Buy	56,601 +8,143	+17%	+$163K	0.02%	265
2021 Q4	$1.75M	Buy	48,458 +9,273	+24%	+$373K	0.03%	221
2021 Q3	$2.15M	Buy	39,185 +10,840	+38%	+$653K	0.04%	194
2021 Q2	$1.91M	Buy	28,345 +1,601	+6%	+$160K	0.03%	224
2021 Q1	$2.37M	Buy	26,744 +4,795	+22%	+$465K	0.04%	177
2020 Q4	$1.79M	Sell	21,949 -13,773	-39%	-$1.05M	0.04%	204
2020 Q3	$1.63M	Buy	+35,722	New	+$1.99M	0.05%	168

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

ETF Managers Group's CVAC Position: Q1 2023 in Review

ETF Managers Group opened a new position in CureVac (CVAC) in Q1 2023: 76,144 shares worth $531K. The stake represents 0.02% of the portfolio and ranks #439 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in CVAC as recently as Q3 2022.

ETF Managers Group first reported a position in CVAC in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.37M in Q1 2021. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

ETF Managers Group held 76,144 shares of CureVac worth $531K as of Q1 2023.
CureVac was a new ETF Managers Group position in Q1 2023.
CureVac made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #439 holding.
ETF Managers Group first reported a position in CureVac in Q3 2020 and has held it in 10 quarters since.
ETF Managers Group's CureVac position peaked at $2.37M in Q1 2021.
82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.